Viemed Healthcare, Inc. (NASDAQ: VMD)

Viemed Healthcare, Inc. operates as a provider of home medical equipment and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The company's primary service offerings are centered around effective in-home treatment, with clinical practitioners providing therapy and counseling to patients using cutting-edge technology. Viemed's objective is to drive growth by increasing the number of patients served and the level of care provided through its technology-enabled, home-based clinical care and chronic disease management model. The company serves patients in all 50 states and anticipates expanding its workforce of licensed clinical practitioners, including respiratory therapists, to support growth and maintain high service standards.

Viemed generates revenue through the rental and sale of various home medical equipment devices, as well as through the provision of related services. The company's primary products include home ventilation devices (both invasive and non-invasive), BiPAP and CPAP machines, percussion vests, oxygen concentrators, and other medical equipment. Additionally, Viemed offers women's health products and services, including breast pumps and related lactation equipment and supplies. The company's customer base includes patients with chronic respiratory diseases and neuromuscular conditions, as well as healthcare facilities seeking staffing and recruitment services.

• Respiratory Disease Management: This segment focuses on the treatment of Chronic Obstructive Pulmonary Disease (COPD) and other respiratory conditions. Viemed provides non-invasive ventilation (NIV), percussion vests, and other therapies to improve the quality of life for patients and reduce hospital readmissions. The segment caters to patients requiring respiratory support and aims to deliver high-touch care models.

• Neuromuscular Care: This segment is designed to help neuromuscular patients breathe more comfortably and live healthier lives. Viemed offers respiratory therapy treatments that reduce the effort required to breathe, catering to patients with neuromuscular conditions.

• Oxygen Therapy: This segment provides patients with extra oxygen to manage chronic health problems, including COPD. Oxygen therapy can be performed in the home or other settings, catering to patients requiring supplemental oxygen.

• Sleep Apnea Management: Viemed provides sleep solutions and equipment, such as Positive Airway Pressure (PAP) devices, AutoPAP machines, and BiPAP machines. The company also offers in-home sleep apnea testing services, providing an alternative to traditional sleep lab testing environments.

• Women's Health: This segment offers breast pumps and related lactation equipment and supplies, catering to eligible patients as part of Viemed's home medical equipment offerings.

• Healthcare Staffing: Viemed provides healthcare staffing and recruitment services to supplement the workforce needs of third-party healthcare facilities. The company utilizes its network of healthcare professionals to offer tailored workforce solutions.

Viemed Healthcare operates in a highly competitive respiratory care industry. While it is one of the top providers of non-invasive ventilation and related services in the United States, its competitors may gain market share, and new entrants with greater financial and technical resources may emerge. The company's competitive advantages include its focus on effective in-home treatment, the use of cutting-edge technology, and a high-touch care model. Viemed's clinical practitioners are licensed members of the American Association for Respiratory Care, ensuring high standards of care. The company's Chief Medical Officer, Dr. William Frazier, a board-certified pulmonary disease specialist, oversees clinical protocols, further enhancing Viemed's competitive position.

Viemed earns revenues by seeking reimbursement from Medicare and private health insurance companies, with the Medicare program of the United States government being the primary entity making payments. The company's revenues are derived from the fee-for-service pricing guidelines set by the Centers for Medicare & Medicaid Services (CMS), which are subject to change at the discretion of CMS. For the years ended December 31, 2025 and 2024, Viemed had no customers that accounted for 10% or more of its consolidated revenue streams. The company's general customer base includes patients with chronic respiratory diseases and neuromuscular conditions, as well as healthcare facilities seeking staffing and recruitment services.